Corvus Pharma Com (CRVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,740 | 12,620 | 13,159 | 63,458 | 16,455 |
| Marketable Securities | 43,224 | 14,529 | 29,144 | 5,993 | 27,804 |
| Receivables | 75 | 26 | 588 | 507 | N/A |
| TOTAL | $54,407 | $27,956 | $43,664 | $71,312 | $45,336 |
| Non-Current Assets | |||||
| PPE Net | 151 | 236 | 353 | 451 | 906 |
| Investments And Advances | 12,540 | 16,123 | 21,877 | 34,266 | 37,225 |
| Other Non-Current Assets | 1,809 | 1,238 | 2,346 | 3,426 | 2,062 |
| TOTAL | $14,500 | $17,597 | $24,576 | $38,143 | $40,193 |
| Total Assets | $68,907 | $45,553 | $68,240 | $109,455 | $85,529 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,582 | 1,525 | 1,976 | 1,565 | 3,467 |
| Accrued Expenses | 3,725 | 3,970 | 7,548 | 7,081 | 7,604 |
| Other current liabilities | 28,910 | N/A | N/A | N/A | N/A |
| TOTAL | $35,402 | $6,869 | $10,752 | $9,692 | $12,149 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 937 | 0 | 1,373 | 2,601 | 1,232 |
| TOTAL | $937 | $N/A | $1,373 | $2,601 | $1,232 |
| Total Liabilities | $36,339 | $6,869 | $12,125 | $12,293 | $13,381 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 68,136 | 49,039 | 46,569 | 46,554 | 38,310 |
| Common Shares | 7 | 5 | 5 | 5 | 3 |
| Retained earnings | -397,010 | -334,717 | -307,688 | -266,381 | -223,140 |
| Other shareholders' equity | -1,288 | -967 | -563 | 1,869 | 4 |
| TOTAL | $32,568 | $38,684 | $56,115 | $97,162 | $72,148 |
| Total Liabilities And Equity | $68,907 | $45,553 | $68,240 | $109,455 | $85,529 |